Epidermal Growth Factor Receptor in the Prawn Macrobrachium rosenbergii: Function and Putative Signaling CascadeSHARABI, Omri; VENTURA, Tomer; MANOR, Rivka et al.Endocrinology (Philadelphia). 2013, Vol 154, Num 9, pp 3188-3196, issn 0013-7227, 9 p.Article

Downregulation of EGFR by a novel multivalent nanobody-liposome platformOLIVEIRA, Sabrina; SCHIFFELERS, Raymond M; VAN DER VEEKEN, Joris et al.Journal of controlled release. 2010, Vol 145, Num 2, pp 165-175, issn 0168-3659, 11 p.Article

Inhibition of the T790M gatekeeper mutant of the epidermal growth factor receptor by EXEL-7647GENDREAU, Steven B; VENTURA, Richard; JACKMAN, Lisa et al.Clinical cancer research. 2007, Vol 13, Num 12, pp 3713-3723, issn 1078-0432, 11 p.Article

Cetuximab : Significant clinical value after platinum failureJournal of cancer research and clinical oncology. 2006, Vol 132, pp 11-13, issn 0171-5216, 3 p., SUP3Conference Paper

Novel Role of MDA-9/Syntenin in Regulating Urothelial Cell Proliferation by Modulating EGFR SignalingDASGUPTA, Santanu; MENEZES, Mitchell E; DAS, Swadesh K et al.Clinical cancer research (Print). 2013, Vol 19, Num 17, pp 4621-4633, issn 1078-0432, 13 p.Article

Dermatologic side effects associated with the epidermal growth factor receptor inhibitorsAGERO, Anna Liza C; DUSZA, Stephen W; BENVENUTO-ANDRADE, Cristiane et al.Journal of the American Academy of Dermatology. 2006, Vol 55, Num 4, pp 657-670, issn 0190-9622, 14 p.Article

Novel combinations based on epidermal growth factor receptor inhibitionADJEI, Alex A.Clinical cancer research. 2006, Vol 12, Num 14, issn 1078-0432, 4446s-4450s, 2Conference Paper

Dissociation of Epidermal Growth Factor Receptor and ErbB2 Heterodimers in the Presence of Somatostatin Receptor 5 Modulate Signaling PathwaysKHARMATE, Geetanjali; RAJPUT, Padmesh S; WATT, Heather L et al.Endocrinology (Philadelphia). 2011, Vol 152, Num 3, pp 931-945, issn 0013-7227, 15 p.Article

Monoubiquitinylation Regulates Endosomal Localization of Lst2, a Negative Regulator of EGF Receptor SignalingMOSESSON, Yaron; CHETRIT, David; WARDEN, Yosef et al.Developmental cell. 2009, Vol 16, Num 5, pp 687-698, issn 1534-5807, 12 p.Article

Acneiform eruptions associated with epidermal growth factor receptor-targeted chemotherapy. CommentaryDEWITT, Christine A; SIROY, Alan E; STONE, Stephen P et al.Journal of the American Academy of Dermatology. 2007, Vol 56, Num 3, issn 0190-9622, 500-505, 514-517 [10 p.]Article

The EGFR Is Required for Proper Innervation to the SkinMAKLAD, Adel; NICOLAI, Jodi R; BICHSEL, Kyle J et al.Journal of investigative dermatology. 2009, Vol 129, Num 3, pp 690-698, issn 0022-202X, 9 p.Article

Importance of EGFR/ERCC1 Interaction Following Radiation-Induced DNA DamageLICCARDI, Gianmaria; HARTLEY, John A; HOCHHAUSER, Daniel et al.Clinical cancer research (Print). 2014, Vol 20, Num 13, pp 3496-3506, issn 1078-0432, 11 p.Article

Traitements de 2^e et 3^e ligne: chimiothérapie ou TKI de l'EGFR ? = Second and third lines therapies: chemotherapy or EGFR TKI?BUNEL, V; GREILLIER, L.Revue des maladies respiratoires actualités (Print). 2014, Vol 6, Num 2, pp 132-135, issn 1877-1203, 4 p.Article

Treating Patients With EGFR-Sensitizing Mutations: First Line or Second Line—Is There a Difference?MOK, Tony; YANG, Jin-Ji; LAM, Kwok-Chi et al.Journal of clinical oncology. 2013, Vol 31, Num 8, pp 1081-1088, issn 0732-183X, 8 p.Article

Effect of the maternofetal and milk transfer of the anti-epidermal growth factor receptor monoclonal antibody 7A7 in miceGONZALEZ, J. E; LEON, M; HERNANDEZ, I et al.Placenta (Eastbourne). 2011, Vol 32, Num 6, pp 470-474, issn 0143-4004, 5 p.Article

Role of Cell Cycle in Epidermal Growth Factor Receptor Inhibitor-Mediated RadiosensitizationAHSAN, Aarif; HINIKER, Susan M; DAVIS, Mary A et al.Cancer research (Chicago, Ill.). 2009, Vol 69, Num 12, issn 0008-5472, 5108-5114 [7 p.]Article

Epidermal Growth Factor Receptor Inhibitors in Neuro-oncology : Hopes and DisappointmentsBRANDES, Alba A; FRANCESCHI, Enrico; TOSONI, Alicia et al.Clinical cancer research. 2008, Vol 14, Num 4, pp 957-960, issn 1078-0432, 4 p.Article

Structure and Clinical Relevance of the Epidermal Growth Factor Receptor in Human CancerKUMAR, Amit; PETRI, Edward T; HALMOS, Balazs et al.Journal of clinical oncology. 2008, Vol 26, Num 10, pp 1742-1751, issn 0732-183X, 10 p.Article

Latent membrane protein 1-induced EGFR signalling is negatively regulated by TGFa prior to neoplasiaCHARALAMBOUS, Chrystalla T; HANNIGAN, Adele; TSIMBOURI, Penelope et al.Carcinogenesis (New York. Print). 2007, Vol 28, Num 8, pp 1839-1848, issn 0143-3334, 10 p.Article

The phosphoinositide kinase pkfyve mediates epidermal growth factor receptor trafficking to the nucleusKIM, Jayoung; WAN JIN JAHNG; DI VINO, Dolores et al.Cancer research (Baltimore). 2007, Vol 67, Num 19, pp 9229-9237, issn 0008-5472, 9 p.Article

The Epidermal Growth Factor Receptor : A Role in Repair of Radiation-Induced DNA DamageCHEN, David J; NIRODI, Chaitanya S.Clinical cancer research. 2007, Vol 13, Num 22, pp 6555-6560, issn 1078-0432, 6 p., 1Article

Les inhibiteurs de l'EGFR = EGFR inhibitorsMILLERON, Bernard.Revue de pneumologie clinique (Paris). 2007, Vol 63, Num 1, issn 0761-8417, 20 p., CAH2Serial Issue

Crosstalk between the EGFR and other signalling pathways at the level of the global transcriptional corepressor Groucho/TLEHASSON, P; PAROUSH, Z.British journal of cancer. 2006, Vol 94, Num 6, pp 771-775, issn 0007-0920, 5 p.Article

ErbB3-dependent motility and intravasation in breast cancer metastasisCHENGSEN XUE; FUBO LIANG; SEGALL, Jeffrey E et al.Cancer research (Baltimore). 2006, Vol 66, Num 3, pp 1418-1426, issn 0008-5472, 9 p.Article

The epidermal growth factor receptor pathway : A model for targeted therapy : Predictive preclinical models of human cancer: Mouse models get another chanceSCALTRITI, Maurizio; BASELGA, José.Clinical cancer research. 2006, Vol 12, Num 18, pp 5268-5272, issn 1078-0432, 5 p.Article